24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Nasdaq
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:48
Israel’s gaming industry employs 14,000 workers and makes up 2% of the GDP
15:44
Innoviz secures $80M in development funding as cash reserves run thin
15:22
"Israeli companies are responsible for 5% of global mobile game downloads"
15:18
"Google's AI models allow users to generate content and integrate it into games in real-time"
More stories
Buzz
Most popular
Daily
Weekly
1
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
2
$41B in exits: Why Israeli cyber startups are a global powerhouse
3
Israeli fintech Morning acquired for $150 million by Italy's TeamSystem
4
AI startup Aporia in talks to be acquired for tens of millions of dollars
5
Kaltura exploring sale or merger at $400-$500M valuation
More news
Nasdaq
6 stories about Nasdaq
Private Investment Terms Dampen Forescout’s Successful IPO
29.10.17
|
Lilach Baumer
On Friday, Forescout raised $116 million on its Nasdaq debut, selling 5.3 million shares at $22 per share
ForeScout Updates Prospectus, Targets a $942 Million Valuation for IPO
19.10.17
|
Dror Reich
The information security company aims to raise $96-$105.6 million in a Nasdaq IPO
Israel’s Flagship Company Stayed its Course
16.10.17
|
Dror Reich
The share price of veteran cybersecurity company Check Point reached a record-breaking $120 over the weekend
Forescout Files For $100 Million Nasdaq IPO
04.10.17
|
Dror Reich
Underwriters for the intended initial public offering are Morgan Stanley and J.P. Morgan
Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO
31.08.17
|
Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
Anti-Acne Drug Developer Plans Nasdaq IPO
15.08.17
|
Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year
Previous Articles
Please ensure Javascript is enabled for purposes of
website accessibility